What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?. Frontiers. 2023;10. doi:10.3389/fmed.2023.1268748
Yeh C, Zhou M, Sigel K, Jameson G, White R, Safyan R, Saenger Y, Hecht E, Chabot J, Schreibman S, Ychou M, Conroy T, Fojo T, Manji G, Von Hoff D, Bates S Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data. Oncologist. 2023;28(2):139-148. doi:10.1093/oncolo/oyac217
Bordeau K, Michalet M, Keskes A, Valdenaire S, Debuire P, Cantaloube M, Cabaillé M, Jacot W, Draghici R, Demontoy S, Quantin X, Ychou M, Assenat E, Mazard T, Gauthier L, Dupuy M, Guiu B, Bourgier C, Fenoglietto P, Azria D, Riou O Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study. J Clin Med. 2023;12(3):1183. doi:10.3390/jcm12031183
Aptecar L, Puech C, Lopez-Crapez E, Peter M, Coopman P, D'Hondt V, Freiss G PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells. Int J Mol Sci. 2023;24(20):15413. doi:10.3390/ijms242015413
Pisareva E, Mihalovi?ová L, Mirandola A, Pastor B, Kudriavtsev A, Berger M, Roubille C, Fesler P, Klouche K, Cristol J-P, Thierry A Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients. J Med Virol. 2023;95(1):e28209. doi:10.1002/jmv.28209
Thierry A Netosis creates a link between diabetes and Long COVID. Physiol Rev. 2023-10-19. doi:10.1152/physrev.00032.2023
André T, Tougeron D, Piessen G, Louvet C, Adenis A, Jary M, Tournigand C, Aparicio T, Desrame J, Lièvre A, Garcia-Larnicol M-L, Pudlarz T, Cohen R, Memmi S, Vernerey D, Henriques J, Svrcek M Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study. J Clin Oncol. 2023;41(2):255-265. doi:10.1200/JCO.22.00686
Al Amir Dache Z, Thierry A Mitochondria-derived cell-to-cell communication. Cell Rep. 2023;42(7):112728. doi:10.1016/j.celrep.2023.112728
Villemin J-P, Bassaganyas L, Pourquier D, Boissière F, Cabello-Aguilar S, Crapez E, Tanos R, Cornillot E, Turtoi A, Colinge J Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR. Nucleic Acids Res. 2023-05-05. doi:10.1093/nar/gkad352
Faron M, Cheugoua-Zanetsie M, Tierney J, Thirion P, Nankivell M, Winter K, Yang H, Shapiro J, Vernerey D, Smithers B, Walsh T, Piessen G, Nilsson M, Boonstra J, Ychou M, Law S, Cunningham D, de Vathaire F, Stahl M, Urba S, Valmasoni M, Williaume D, Thomas J, Lordick F, Tepper J, Roth J, Gebski V, Burmeister B, Paoletti X, van Sandick J, Fu J, Pignon J-P, Ducreux M, Michiels S Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma. J Clin Oncol. 2023;41(28):4535-4547. doi:10.1200/JCO.22.02279
Cherradi S, Garambois V, Marines J, Andrade A, Fauvre A, Morand O, Fargal M, Mancouri F, Ayrolles-Torro A, Vezzo-Vié N, Jarlier M, Loussaint G, Huvelle S, Joubert N, Mazard T, Gongora C, Pourquier P, Boissière-Michot F, Rio M Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells. Cell Biosci. 2023;13(1):72. doi:10.1186/s13578-023-01015-5
Rouanet P, Castan F, Mazard T, Lemanski C, Nougaret S, Deshayes E, Chalbos P, Gourgou S, Taoum C GRECCAR 14 - a multicentric, randomized, phase II-III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol. Colorectal Dis. 2023;25(10):2078-2086. doi:10.1111/codi.16740
Alouani E, Mercier M, Flecchia C, Auclin E, Hollebecque A, Mazard T, Turpin A, Pernot S, Cohen R, Dutherage M, Kim S, Sclafani F, Ben-Abdelghani M, Herve C, Aparicio T, De La Fouchardière C, Perkins G, Hautefeuille V, Jaffrelot M, Gallois C, Bongard V, Tougeron D, Guimbaud R Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study. ESMO Open. 2023;8(3):101574. doi:10.1016/j.esmoop.2023.101574
Sayah L, Heinrich K, Kunzmann V, Boileve A, Cirkel G, Lonardi S, Chibaudel B, Turpin A, Beller T, Hautefeuille V, Vivaldi C, Mazard T, Bauguion L, Niger M, Prager G, Coutzac C, Benedikt Westphalen C, Auclin E, Pilla L Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort. Eur J Cancer. 2023;188. doi:10.1016/j.ejca.2023.04.012
Pisareva E, Sanchez C, Pastor B, Mirandola A, Diab-Assaf M, Mazard T, Prévostel C, Al Amir Dache Z, Thierry A Comparison of the structures and topologies of plasma extracted circulating nuclear and mitochondrial cell-free DNA. Front Genet. 2023;14. doi:10.3389/fgene.2023.1104732
Thierry A, Sanchez C, Colinge J, Pisareva E Circulating DNA reveals a specific and higher fragmentation of the Y chromosome. Hum Genet. 2023;142(11):1603-1609. doi:10.1007/s00439-023-02600-x
Thierry A Circulating DNA fragmentomics and cancer screening. Cell Genom. 2023;3(1):100242. doi:10.1016/j.xgen.2022.100242
Velazquez C, Orhan E, Tabet I, Fenou L, Orsetti B, Guille A, Crapez E, Colombo P-E, Chaffanet M, Birnbaum D, Sardet C, Jacot W, Theillet C BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib. Front Oncol. 2023;13. doi:10.3389/fonc.2023.1125021
Grosgeorges M, Picque Lasorsa L, Pastor B, Prévostel C, Crapez E, Sanchez C, Frayssinoux F, Jarlier M, Monard L, Ychou M, Thierry A, Mazard T, Blache P A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer. Sci Rep. 2023;13(1):2739. doi:10.1038/s41598-023-29948-4
Bordeau K, Michalet M, Dorion V, Keskes A, Valdenaire S, Debuire P, Cantaloube M, Cabaillé M, Draghici R, Ychou M, Assenat E, Jarlier M, Gourgou S, Guiu B, Fenoglietto P, Azria D, Riou O A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors. Radiother Oncol. 2023;189. doi:10.1016/j.radonc.2023.109912
Thierry A, Pisareva E A New Paradigm of the Origins of Circulating DNA in Patients with Cancer. Cancer Discov. 2023;13(10):2122-2124. doi:10.1158/2159-8290.CD-23-0824
Assenat E, Payen L, Mazard T, Glehen O, Calattini S, Villeneuve L, Lescuyer G, Vire B, Ychou M [hPG80 and cancer: A new blood biomarker in development for patient monitoring]. Bull Cancer. 2022;109(6):707-713. doi:10.1016/j.bulcan.2022.03.009
Folprecht G, Martinelli E, Mazard T, Modest D, Tsuji A, Esser R, Cremolini C, Falcone A Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives. Cancer Treat Rev. 2022;102. doi:10.1016/j.ctrv.2021.102301
Giguelay A, Turtoi E, Khelaf L, Tosato G, Dadi I, Chastel T, Poul M-A, Pratlong M, Nicolescu S, Severac D, Adenis A, Sgarbura O, Carrère S, Rouanet P, Ychou M, Pourquier D, Colombo P-E, Turtoi A, Colinge J The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases. Theranostics. 2022;12(17):7624-7639. doi:10.7150/thno.72853
Khellaf L, Quénet F, Jarlier M, Gil H, Pissas M-H, Carrère S, Samalin E, Mazard T, Ychou M, Sgarbura O, Bibeau F The desmoplastic growth pattern is associated with second-stage completion and longer survival in 2-stage hepatectomy for colorectal cancer liver metastases. Surgery. 2022;172(5):1434-1441. doi:10.1016/j.surg.2022.06.032